ReviewThe Lancet. Global health2022
Robustness of evidence reported in preprints during peer review.
Review in The Lancet. Global health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Efficacy and safety of GLP-1 agonists in Parkinson's disease: a systematic review and meta-analysis of randomized controlled trials.Naunyn-Schmiedeberg's archives of pharmacology · 2025Pooled it
- A systematic review and meta-analysis of the global prevalence and determinants of COVID-19 vaccine acceptance and uptake in people living with HIV.Nature human behaviour · 2024Pooled it
- Discovery Stack Pilot demonstrates the feasibility and outcomes of a scientist-designed peer-review model that separates quality and impact.PLoS biology · 2026Article
- Comparing the outputs of intramural and extramural grants funded by National Institutes of Health.eLife · 2026Article
- Prediction of transformative breakthroughs in biomedical research.bioRxiv : the preprint server for biology · 2025Article
- Can I trust this paper?Psychonomic bulletin & review · 2025Review
- Most researchers would receive more recognition if assessed by article-level metrics than by journal-level metrics.PLoS biology · 2025Article
- The academic impact of Open Science: a scoping review.Royal Society open science · 2025Review
- The present and future of peer review: Ideas, interventions, and evidence.Proceedings of the National Academy of Sciences of the United States of America · 2025Article
- Evidence for the Efficacy of COVID-19 Convalescent Plasma.Current topics in microbiology and immunology · 2025Review
- Phase 1 of the National Institutes of Health Preprint Pilot: Testing the viability of making preprints discoverable in PubMed Central and PubMed.bioRxiv : the preprint server for biology · 2024Article
- Predicting substantive biomedical citations without full text.Proceedings of the National Academy of Sciences of the United States of America · 2023Article
- Article
- Current concerns on journal article with preprint: Korean Journal of Internal Medicine perspectives.The Korean journal of internal medicine · 2023Review
- Current concerns on journal article with preprint: Anesthesia and Pain Medicine perspectives.Anesthesia and pain medicine · 2023Review
- Preprints versus peer-reviewed articles.The Lancet. Global health · 2023Article
- Preprints versus peer-reviewed articles - Author's reply.The Lancet. Global health · 2023Article
- Robustness of evidence reported in preprints during peer review.The Lancet. Global health · 2022Review
- [[How Is Evidence Constructed in 2024?: Levels of Evidence, Strengths of Recommendation, Preprints and Regional Bibliographies]].Acta gastroenterologica LatinoamericanaArticle
Corrections and comments
- Commented on by
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Scientists have expressed concern that the risk of flawed decision making is increased through the use of preprint data that might change after undergoing peer review. This Health Policy paper assesses how COVID-19 evidence presented in preprints changes after review. We quantified attrition dynamics of more than 1000 epidemiological estimates first reported in 100 preprints matched to their subsequent peer-reviewed journal publication. Point estimate values changed an average of 6% during review; the correlation between estimate values before and after review was high (0·99) and there was no systematic trend. Expert peer-review scores of preprint quality were not related to eventual publication in a peer-reviewed journal. Uncertainty was reduced during peer review, with CIs reducing by 7% on average. These results support the use of preprints, a component of biomedical research literature, in decision making. These results can also help inform the use of preprints during the ongoing COVID-19 pandemic and future disease outbreaks.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.